This Government Contract opportunity from Department Of Health And Human Services was posted on April 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Sole Source – Agilent Technologies
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health Clinical Center’s Center for Cellular Engineering intends to award a sole-source, fixed-price purchase order to Agilent Technologies for reagents and preventative maintenance services for the Seahorse XFe96 analyzer, a critical instrument used to measure metabolic activity in cellular therapies such as CAR T cells, which is essential for the release of patient-derived cellular products. Agilent is the sole provider authorized to perform preventative maintenance on this device, ensuring compliance with FDA regulations including 21 CFR 211.67, and the instrument's continued operational integrity for clinical and research applications. The acquisition falls under the Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, permitting a non-competitive award due to the unique nature of the equipment and the absence of alternative vendors capable of providing certified maintenance and compatible reagents. The place of performance is Bethesda, Maryland, and the contract is classified under NAICS code 339112 and Product Service Code 6515. This notice is not a solicitation for quotes but a formal announcement to allow potential vendors to express interest; however, the government retains full discretion to proceed without competition based on its determination that Agilent is the only reasonably available source. Comments and responses must be submitted to Kristin Nagashima via email by May 4, 2026 at 2 p.m. EST.
General Info
Agency
NAICS
Place of Performance
MD, 20892Set-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
This acquisition is for reagents and preventative maintenance for the Seahorse XFEe Analyzer at the National Institutes of Health (NIH) Clinical Center (CC) Center for Cellular Engineering.
• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-000161
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Agilent Technologies, located at 121 Hartwell Ave, Lexington, MA 02421, on a firm fixed price sole source award basis to provide reagents and preventative maintenance services to the National Institutes of Health.
The proposed vendor, Agilent technologies, provides the clinically approved platform for reagents, kits, and the respective instruments that may be used for patient care testing on clinical and research cellular products. Preventive maintenance is required to compliance with the manufacturer and FDA 21 CFR 211.67. The Seahorse XFe96 is a unique instrument that can help us measure cellular potency using metabolic activity following CAR T cell and other cell product of manufacturing. This instrument is needed to generate data that is required for the release of the cellular therapy product. Agilent technologies is the sole vendor that provides the periodic Preventive Maintenance (PM) for this type of device.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by May 4, 2026 at 2pm EST.
More opportunities from Department Of Health And Human Services → National Institutes Of Health - Cc
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
